ARCHIVES

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010

Samuel Broder Plans To Leave Celera.

September 10, 2010

FDA Encourages Study Of Gender Differences

August 6, 1993

CPSC Relies On NCI Findings For New Policy

July 21, 1978

Avon Gives $3 Million To Expand CDC’s Screening Program

February 18, 1994

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 5, 1990